Related Experiment Videos
Extranodal hematopoietic/lymphoid disorders. An introduction
1Department of Anatomic Pathology, Alta Bates Medical Center, Berkeley, California 94705, USA.
American Journal of Clinical Pathology
|January 23, 1999
Summary
Extranodal lymphomas, including mucosa-associated lymphoid tissue (MALT) lymphomas and aggressive B-cell types, are increasing. Distinguishing these from benign conditions and other lymphomas is crucial for accurate diagnosis and treatment.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Extranodal lymphomas are rising due to true increases, AIDS, and improved diagnostic recognition of mucosa-associated lymphoid tissue (MALT) lymphomas.
- While low-grade MALT lymphomas are increasingly identified, most primary extranodal lymphomas are aggressive, typically large B-cell types.
- Extranodal T-cell lymphomas, including NK/T-cell and anaplastic large cell types, also present significant diagnostic challenges.
Purpose of the Study:
- To highlight the increasing incidence and diverse types of extranodal lymphomas.
- To emphasize the critical need for accurate differentiation between malignant lymphomas and benign lymphoid hyperplasias or other lymphoid neoplasms.
- To discuss the diagnostic complexities and the potential designation of "uncertain malignant potential" in challenging cases.
Main Methods:
- Review of current literature and pathological classifications of extranodal lymphomas.
- Comparative analysis of diagnostic criteria for low-grade MALT lymphomas, aggressive lymphomas, and extranodal lymphoid hyperplasias.
- Discussion of differential diagnoses, including myeloid leukemias and small B-cell lymphomas (mantle cell, follicular).
Main Results:
- Extranodal lymphomas encompass a spectrum from low-grade MALT lymphomas to aggressive large B-cell and T-cell lymphomas.
- Accurate distinction is required to differentiate aggressive lymphomas from myeloid leukemias and low-grade lymphomas from benign conditions.
- The presence of clonal populations in extranodal lymphocytic infiltrates does not always confirm lymphoma, necessitating careful evaluation.
Conclusions:
- The increasing frequency and varied presentations of extranodal lymphomas demand precise diagnostic approaches.
- Distinguishing malignant extranodal lymphomas from reactive conditions and other lymphoid neoplasms is essential for appropriate patient management.
- A diagnosis of "uncertain malignant potential" may be warranted for extranodal lymphocytic infiltrates with clonal populations but ambiguous features.